Dr. د مسعود الزريقي

Professional Profile and Career Journey

Dr. Masoud Al-Zureiqi is a distinguished expert in Medical Oncology with over 17 years of dedicated clinical experience. Throughout his career, he has been at the forefront of cancer research and patient care, currently serving as a Senior Consultant at Eiadaty Health System. His practice focuses on evidence-based medicine combined with personalized care, ensuring that every patient receives a treatment plan tailored to their unique genetic and physiological profile.

Subspecialties and Clinical Interests

Dr. Al-Zureiqi specializes in complex oncology cases, including gastrointestinal malignancies, breast cancer, and genitourinary cancers. His primary interest lies in the advancement of immunotherapy and precision oncology, focusing on therapies that identify and neutralize cancerous cells while sparing healthy tissues, thereby significantly improving patient outcomes and quality of life.

Clinical Procedures and Management

Dr. Al-Zureiqi oversees comprehensive cancer management, including:
1. Targeted chemotherapy protocols based on molecular analysis.
2. Advanced immunotherapy and monoclonal antibody treatments.
3. Multidisciplinary coordination for radiation therapy planning.
4. Image-guided biopsy oversight for accurate diagnosis.
5. Long-term surveillance and survivorship programs to prevent recurrence.

Modern Diagnostic Technologies

At Eiadaty, Dr. Al-Zureiqi utilizes cutting-edge molecular profiling to identify actionable mutations. By leveraging PET-CT imaging and liquid biopsy techniques, he monitors tumor progression in real-time, allowing for rapid adjustment of treatment strategies to ensure the highest success rate in therapy response.

Medical Guidance for Patients

Dr. Al-Zureiqi emphasizes that holistic care is essential. Before treatment, patients are educated on the specifics of their diagnosis. Post-treatment, his team provides structured survivorship plans, including nutritional counseling, exercise regimens to bolster immune response, and psychological support to ensure overall well-being.

Frequently Asked Questions (FAQ)

Q: Is immunotherapy a replacement for traditional chemotherapy?
A: Immunotherapy acts on the immune system, whereas chemotherapy targets rapidly dividing cells. Depending on the cancer type, they are sometimes used independently or in combination.
Q: How do you manage side effects?
A: We utilize a supportive care model, integrating pain management, nutritional support, and psychological services to mitigate side effects effectively.
Q: Why is genetic testing necessary?
A: Genetic testing allows us to identify the specific drivers of a patient's cancer, enabling the use of targeted drugs that are far more effective than standard treatments.